Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-04

FDA Approved: GLIPIZIDE AND METFORMIN HCL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for a generic fixed-dose combination of glipizide and metformin hydrochloride (GLIPIZIDE AND METFORMIN HCL) from Her…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLIPIZIDE AND METFORMIN HCL (GLIPIZIDE AND METFORMIN HCL)

Snippet

SUPPL AP for GLIPIZIDE AND METFORMIN HCL (GLIPIZIDE AND METFORMIN HCL)